Ahn-Gook Pharmaceutical Co Ltd banner
A

Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540

Watchlist Manager
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Watchlist
Price: 8 190 KRW Market Closed
Market Cap: ₩93.1B

Ahn-Gook Pharmaceutical Co Ltd
Short-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Ahn-Gook Pharmaceutical Co Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
A
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Short-Term Debt
₩22.3B
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
8%
Yuhan Corp
KRX:000100
Short-Term Debt
₩199.8B
CAGR 3-Years
46%
CAGR 5-Years
33%
CAGR 10-Years
12%
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Debt
₩319.5B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
24%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Debt
₩11.8B
CAGR 3-Years
62%
CAGR 5-Years
42%
CAGR 10-Years
10%
C
Caregen Co Ltd
KOSDAQ:214370
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ahn-Gook Pharmaceutical Co Ltd
Glance View

Market Cap
93.1B KRW
Industry
Pharmaceuticals

AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.

Intrinsic Value
15 843.67 KRW
Undervaluation 48%
Intrinsic Value
Price ₩8 190
A

See Also

What is Ahn-Gook Pharmaceutical Co Ltd's Short-Term Debt?
Short-Term Debt
22.3B KRW

Based on the financial report for Dec 31, 2025, Ahn-Gook Pharmaceutical Co Ltd's Short-Term Debt amounts to 22.3B KRW.

What is Ahn-Gook Pharmaceutical Co Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
8%

Over the last year, the Short-Term Debt growth was -18%. The average annual Short-Term Debt growth rates for Ahn-Gook Pharmaceutical Co Ltd have been 5% over the past three years , 2% over the past five years , and 8% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett